SalutarisMD Data for Wet AMD Treatment with Long Term Positive Outcomes Presented at EURETINA Congress
9/27/2013 7:05:29 AM
At the 13th EURETINA Congress yesterday, results were presented from a cohort study evaluating the use of a minimally invasive retrobulbar episcleral brachytherapy device developed by Salutaris Medical Devices, Ltd. (SalutarisMD®) to treat wet AMD (age-related macular degeneration), the leading cause of vision loss and blindness.
Help employers find you! Check out all the jobs and post your resume.
comments powered by